Tag: NephroSant
NephroSant launches two-year AQUA study involving 2,000 kidney transplant recipients
NephroSant has today announced enrolment of the first patient in its AQUA (Assessment of QSant for underlying allograft rejection) study. Eligible participants will have...
NephroSant publishes real-world data on potential of QSant test in kidney...
NephroSant has announced that the Journal of Clinical Medicine has published real-world data that provides insight into how changes in allograft health are reflected in...